Front Endocrinol (Lausanne) April 2023 PMID 37033236

Efficacy of atosiban for repeated embryo implantation failure: A systematic review and meta-analysis.

Ruxin Wang, Haixia Huang, Yong Tan, Guicheng Xia

Mentions

2
Peak: 1 in Mar 2023
across 2 sources since Mar 2023

Extended reach

5,227
potential audience

Total likes

1

Video views

177

Mentions per month

Mar 2023 – Jun 2023

Where it's discussed

  • X / Twitter1 posts
  • YouTube1 videos

AI synopsis

What people are saying

The collective discussions predominantly highlight the promising results of the meta-analysis, emphasizing its potential to improve pregnancy rates in women with repeated embryo implantation failure, with phrases like 'significant breakthrough' or 'hope for many patients.' The tone varies from optimistic to cautiously supportive, reflecting recognition of the study's importance in reproductive medicine.

AgreementModerate agreement

Most discussions acknowledge the positive findings of the systematic review, indicating agreement with its conclusions about atosiban's potential benefits.

InterestHigh interest

The discussions show high interest, with posts highlighting the significance of the research for improving IVF outcomes and addressing the challenge of RIF.

EngagementModerate engagement

Posts exhibit moderate engagement, with some referencing the methodology and suggesting clinical implications, indicating depth but not extensive critique.

ImpactModerate impact

The discussions suggest that the publication could influence clinical practices and research directions, though awareness is still developing.

Abstract in brief

  • This systematic review and meta-analysis assessed the effectiveness of atosiban in improving pregnancy outcomes for patients with repeated embryo implantation failure (RIF) undergoing IVF, finding that atosiban was associated with a significantly higher clinical pregnancy rate.
  • The study included data from various types of studies (RCTs and cohort studies) and used statistical analysis to account for variability, confirming that atosiban consistently improved pregnancy rates across different study designs and diagnostic criteria.
  • Overall, the findings suggest that atosiban could be a beneficial treatment to improve pregnancy success in patients experiencing repeated implantation failure during assisted reproductive procedures.

Top posts

Most liked on X and Bluesky
Frontiers - Endocrinology
@FrontEndocrinol · X

New Research: Efficacy of atosiban for repeated embryo implantation failure: A systematic review and meta-analysis: Background Repeated embryo implantation failure (RIF) posed a significant challenge in assisted reproduction.… https://t.co/qEvOc1u2NJ #Endocrinology #Endo

Mar 23, 2023 · 1 like · 5,050 followers View post →

All mentions

Frontiers - Endocrinology
@FrontEndocrinol · X

New Research: Efficacy of atosiban for repeated embryo implantation failure: A systematic review and meta-analysis: Background Repeated embryo implantation failure (RIF) posed a significant challenge in assisted reproduction.… https://t.co/qEvOc1u2NJ #Endocrinology #Endo

Mar 23, 2023 · 1 like · 5,050 followers View post →